Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions. - Wikidata - awgldk - TriplyDB

Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

http://www.wikidata.org/entity/Q37977063

about

Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma Cells Systemic virotherapy for multiple myeloma.

P2860

Q36538951-885E8B8A-2618-4EEA-8B4F-B6C2BF445944 Q39633869-A6DD50F4-6F8F-47CF-8C94-445CA25D4B06 Q40087770-67C13112-1194-45FB-9A36-BAE956EB20A3

P2860

Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

http://www.wikidata.org/entity/Q37977063

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

@en

Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

@nl

type

label

Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

@en

Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

@nl

prefLabel

Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

@en

Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

@nl

P1433

Q37977063-7FEF2327-9C6E-4372-B42F-902959778FBA

P1476

Q37977063-41E4CEDB-9964-4AEB-8F3C-3D393A226EAA

P2093

Q37977063-0C6639F5-5099-4B0C-A31F-0D62615796E4

Q37977063-13F303C6-A80F-450B-B966-AA595042CE7E

Q37977063-61020B75-829E-48B0-84F5-22CE6BAE05C1

P2860

Q37977063-00CCFFD0-990A-438E-A4BB-C50258C337C6

Q37977063-04956063-6246-4E28-B93A-C11A71461FCD

Q37977063-04E8BA82-0FFD-449C-A22F-2A02AEE7B749

Q37977063-095DFA7F-963A-4080-8D9C-B21043BBE1B0

Q37977063-0C6B953C-3A68-4866-8201-59EF0825CCAC

Q37977063-12E7B3B9-DC6A-44BF-983A-DCD876559A32

Q37977063-1B3A2583-25AF-46EC-9025-35F613037D68

Q37977063-1B97EF50-200D-4406-9C8D-0A94F8E2BC14

Q37977063-1C22CE43-D275-4EB2-9763-F800B74A6CBB

Q37977063-1CA20CDD-6A83-4AC0-B598-C392FBBF7116

P304

Q37977063-E57B327E-0F9D-4E3A-A3BB-81FF11136BCB

P31

Q37977063-4A8D5D6A-6A46-4533-A37D-F15C38735C72

P356

Q37977063-E6C45152-FD09-458E-8176-762691AC1971

P433

Q37977063-C1BBB39A-1159-4858-BFA9-69413A9B6377

P478

Q37977063-FB93B025-4AE7-48CC-85D3-8ABEEB121A09

P577

Q37977063-2D4E39E0-D2F1-4CCA-8197-D95AA900A230

P5875

Q37977063-CEC7A621-B237-4856-B059-32D8A493ACE8

P698

Q37977063-A99B0FE6-AA51-4FEE-A74E-1298032B93CF

P921

Q37977063-31E187F1-6805-4F6D-A5AC-6C7B491869FF

P932

Q37977063-23534181-83E5-49B7-ADC1-EF5300A455B1

P356

KJH.2011.46.4.229

P1433

The Korean Journal of Hematology

P1476

Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

@en

P2093

Silvia Coin

http://www.w3.org/2001/XMLSchema#string

Svjetlana Raus

http://www.w3.org/2001/XMLSchema#string

Vladia Monsurrò

http://www.w3.org/2001/XMLSchema#string

P2860

Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells

Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers

Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide

Multiple myeloma

Coordinated Regulation and Widespread Cellular Expression of Interferon-Stimulated Genes (ISG) ISG-49, ISG-54, and ISG-56 in the Central Nervous System after Infection with Distinct Viruses

Interferon-inducible antiviral effectors

Intrinsic Cellular Defenses against Virus Infection by Antiviral Type I Interferon

Progress and prospects: immune responses to viral vectors

The multifunctional NS1 protein of influenza A viruses

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

P304

229-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5045/KJH.2011.46.4.229

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221761302

http://www.w3.org/2001/XMLSchema#string

P698

22259628

http://www.w3.org/2001/XMLSchema#string

P921

P932

3259514

http://www.w3.org/2001/XMLSchema#string